XNASMODD
Market cap54mUSD
Jan 08, Last price
1.34USD
1D
-4.29%
1Q
-36.49%
IPO
458.33%
Name
Modular Medical Inc
Chart & Performance
Profile
Modular Medical, Inc., a development stage medical device company, focuses on the design, development, and commercialization of insulin pumps using technology to enhance pump adoption in the diabetes marketplace. The company is headquartered in San Diego, California.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|---|
2024‑03 | 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | 2019‑03 | 2018‑03 | 2017‑06 | 2016‑06 | 2015‑06 | |
Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | 18,297 | 14,234 | 15,123 | |||||||
Unusual Expense (Income) | ||||||||||
NOPBT | (18,297) | (14,234) | (15,123) | |||||||
NOPBT Margin | ||||||||||
Operating Taxes | 2 | 2 | 2 | |||||||
Tax Rate | ||||||||||
NOPAT | (18,299) | (14,235) | (15,125) | |||||||
Net income | (17,470) 25.87% | (13,879) -25.51% | (18,633) 152.55% | |||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | 20,343 | 7,372 | 13,785 | |||||||
BB yield | -49.14% | -46.73% | -46.02% | |||||||
Debt | ||||||||||
Debt current | 746 | 355 | 145 | |||||||
Long-term debt | 2,007 | 2,735 | 225 | |||||||
Deferred revenue | ||||||||||
Other long-term liabilities | (33) | |||||||||
Net debt | (6,479) | (709) | (8,707) | |||||||
Cash flow | ||||||||||
Cash from operating activities | (13,952) | (11,012) | (10,260) | |||||||
CAPEX | (1,700) | (1,638) | (55) | |||||||
Cash from investing activities | (1,700) | (1,638) | (55) | |||||||
Cash from financing activities | 21,085 | 7,372 | 17,922 | |||||||
FCF | (19,210) | (17,078) | (14,982) | |||||||
Balance | ||||||||||
Cash | 9,232 | 3,799 | 9,076 | |||||||
Long term investments | ||||||||||
Excess cash | 9,232 | 3,799 | 9,076 | |||||||
Stockholders' equity | (65,897) | (48,448) | (34,569) | |||||||
Invested Capital | 78,995 | 55,069 | 43,591 | |||||||
ROIC | ||||||||||
ROCE | ||||||||||
EV | ||||||||||
Common stock shares outstanding | 22,377 | 10,881 | 6,808 | |||||||
Price | 1.85 27.59% | 1.45 -67.05% | 4.40 -16.19% | |||||||
Market cap | 41,397 162.40% | 15,777 -47.33% | 29,954 -8.15% | |||||||
EV | 34,918 | 15,068 | 21,247 | |||||||
EBITDA | (17,529) | (14,081) | (15,006) | |||||||
EV/EBITDA | ||||||||||
Interest | 2,752 | |||||||||
Interest/NOPBT |